CompletedNot Applicable

Observational Study of LUMRYZ in Narcolepsy

United States71 participantsStarted 2024-07-18

Plain-language summary

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adults with narcolepsy * Oxybate naive or prior treatment with twice-nightly oxybate * Access to smart phone, tablet or laptop with reliable internet connection * Able to read/understand English * Written informed consent and ability to comply with schedule Exclusion Criteria: * Already using LUMRYZ * Clinical or mental health condition excluded by LUMRYZ label * Any other condition/situation that would adversely impact participation

What they're measuring

Epworth Sleepiness Scale

Timeframe: Baseline to Month 4

Trial details

NCT IDNCT06792708

SponsorAvadel

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2025-10-28

View on ClinicalTrials.gov More Narcolepsy trials